Tag archive for ‘CLAL BIOTECHNOLOGY INDUSTRIES LTD’
Jewish Business News On Sunday, October 11th, 2015

Shareholder Novartis to invest additional $15 million in Israeli co Gamida Cell

  Multinational pharmaceutical giant Novartis International AG (NYSE: NVS) has announced that it is investing up to an additional $15 million in Israeli Gamida Cell . Gamida Cell develops cellular and immune More...

Niva Goldberg On Wednesday, September 30th, 2015

Israel’s MediWound signs $112 million deal in U.S. for burn treatment

  Clal Biotechnology Industries Ltd. reported to the Tel Aviv Stock Exchange Today that its wound and burn care solutions unit MediWound Ltd. has been awarded a $112 million contract by the US Biomedical More...

Wordpress site Developed by Fixing WordPress Problems